Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VOC reg

This article was originally published in The Tan Sheet

Executive Summary

Delaware's volatile organic compound rule for consumer products should mirror that developed by Ozone Transport Commission last year, CTFA says in comments to state's Dept. of Natural Resources & Environmental Control. Industry support for VOC rule is contingent on conformation to Northeast and Mid-Atlantic regional model to ensure uniform standards across state lines, association says. OTC rule was developed as model for 12 Northeastern states and D.C., which individually will decide whether to adopt it. Modeled after California's VOC reduction program, rule aims to reduce VOC emissions by 20% in consumer products, including antiperspirants (1"The Tan Sheet" Oct. 9, 2000, p. 6)

You may also be interested in...



VOC Emissions Reg Should Exempt Products Made Before 2005 - CTFA

The Ozone Transport Commission's proposed volatile organic compound emissions reduction regulation should be amended to grandfather all products manufactured before the Jan. 1, 2005 effective date, the Cosmetic, Toiletry & Fragrance Association maintains in Sept. 26 comments to the commission.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093194

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel